NCT05500768

Brief Summary

The aim of this study is to evaluate the efficacy of hypothermic compression bandaging versus conventional compression bandaging, for the prevention of surgical wound hematoma of cardiac implementable electronic devices in patients undergoing chronic oral anticoagulant therapy and/or oral antiplatelet therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
3.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 15, 2022

Completed
Last Updated

August 15, 2022

Status Verified

August 1, 2022

Enrollment Period

1.1 years

First QC Date

August 10, 2022

Last Update Submit

August 11, 2022

Conditions

Keywords

cardiac devicessurgical woundoral anticoagulation therapyoral antiplatelet therapycompression bandagehypothermic therapy

Outcome Measures

Primary Outcomes (1)

  • Appearance of hematoma

    Classification of pocket hematoma according to DeSensi et al.: Grade I: ecchymosis, defined as minor bleeding in the cardiac device pocket, no swelling or pain (watch and wait). Grade II: medium hematoma described as a palpable, bulging mass of \<2cm over the implanted generator. Moderate bleeding in the pocket of the MCP or ICD, causing functional impairment or pain in the area of the heart device Grade III: severe hematoma Determined as a palpable, bulging mass \>2cm. Evacuation is required if it causes tension in the skin with poor tissue perfusion, which is increasing and generates severe pain. Prolongs the patient's hospitalization or readmission for more than 24 hours. Requires immediate discontinuation of OACs or oral antiplatelets

    10 days

Secondary Outcomes (1)

  • Appearance of severe hematoma

    10 days

Study Arms (2)

hypothermic compression bandage

EXPERIMENTAL
Procedure: hypothermic compression bandage

Conventional compression bandage

ACTIVE COMPARATOR
Procedure: Conventional compression bandage

Interventions

a compressive bandage is applied for 8 hours to the surgical wound of the cardiac device implants, a frozen prosthesis is added

Also known as: HCB
hypothermic compression bandage

a compressive bandage is applied for 8 hours to the surgical wound of the cardiac device implants

Also known as: CCB
Conventional compression bandage

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients under oral anticoagulation and/or antiplatelet treatment who were going to undergo implantation of an implanted device cardiac stimulation or generator replacement due to battery depletion

You may not qualify if:

  • insertion of drainage in the wound,
  • non-compliance with the pre-surgical antithrombotic protocol
  • INR in a high therapeutic range (\>3.5)
  • Do not follow-up in the same hospital
  • Coagulation and hemostasis disorders
  • Replacement of devices due to alterations in the operation unrelated to the battery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínic

Barcelona, 08036, Spain

Location

Related Publications (1)

  • Cano Valls A, Niebla M, Diago C, Domingo R, Tolosana JM, Perez S. Efficacy of Hypothermic Compression Bandages in Cardiac Device Surgical Wounds: A Randomized Controlled Trial. Adv Skin Wound Care. 2024 Sep 1;37(9):1-7. doi: 10.1097/ASW.0000000000000201.

MeSH Terms

Conditions

Surgical Wound

Interventions

Hexachlorobenzene

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

ChlorobenzenesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsHydrocarbons, ChlorinatedHydrocarbons, Halogenated

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Arrythmia Unit

Study Record Dates

First Submitted

August 10, 2022

First Posted

August 15, 2022

Study Start

May 1, 2018

Primary Completion

May 31, 2019

Study Completion

July 31, 2022

Last Updated

August 15, 2022

Record last verified: 2022-08

Locations